ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 125

Exposure to Passive Smoking and RA Risk; Results from a Swedish Case-Control Study

Lars Alfredsson1, Anna Karin Hedström2 and Lars Klareskog3, 1The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 2Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 3Dept. of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Rheumatoid arthritis (RA), risk and tobacco use

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Epidemiology and Public Health Poster I: Rheumatoid Arthritis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Smoking has consistently been associated with increased risk of developing rheumatoid arthritis (RA). We investigated the influence of passive smoking on the risk of developing ACPA positive and ACPA negative RA.

Methods: A population-based case-control study using incident cases of RA was performed in Sweden, and the study population in this report was restricted to include never smokers (589 cases, 1764 controls). Cases and controls answered an extensive questionnaire. The incidence of RA among never smokers who had been exposed to passive smoking was compared with that of never smokers who had never been exposed, by calculating the odds ratio (OR) with a 95% confidence interval (CI) employing logistic regression.

Results: No association was observed between exposure to passive smoking and risk of ACPA positive or ACPA negative RA, regardless if the exposure took place within 10 years prior to index, or earlier in life.

Compared with those who had never been exposed to passive smoking, the OR was 1.0 (95% CI 0.7-1.2) for ACPA positive RA, and 0.9 (95% CI 0.7-1.2) for ACPA negative RA among those ever exposed to passive smoking. There were no significant age or gender related differences.

There was no suggestion of a trend between duration of passive smoking and RA risk. Long term exposure to passive smoking for 20 years or longer was not significantly associated with increased disease susceptibility (table 1).

Conclusion: No association was observed between exposure to passive smoking and risk of ACPA positive or ACPA negative RA among never smokers. Our finding may be explained by a threshold below which no association between smoke exposure and RA occurs.


Disclosure: L. Alfredsson, None; A. K. Hedström, None; L. Klareskog, None.

To cite this abstract in AMA style:

Alfredsson L, Hedström AK, Klareskog L. Exposure to Passive Smoking and RA Risk; Results from a Swedish Case-Control Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/exposure-to-passive-smoking-and-ra-risk-results-from-a-swedish-case-control-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exposure-to-passive-smoking-and-ra-risk-results-from-a-swedish-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology